Hong Kong
The changing Hong Kong healthcare market
The launch of innovative drugs will drive growth in the market. Hong Kong is the leading choice for manufacturers of home-based equipment, hygiene-steriliz...
June 15, 2021 | News
Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress
Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's an...
June 08, 2021 | Analysis
Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project
The leader in precision medicine technology, Lifebit Biotech Ltd, today announced it has been awarded a four-year contract by Hong Kong Genome Institute (H...
May 26, 2021 | News
Most COVID-19 Patients Have Long-term Neurological Problems
In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...
May 25, 2021 | Analysis
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
